People

Grant Kardachi AM, (Chair)
Grant is a former national President of PSA, Past Chair of AACP, and has chaired many national and state sub-committees. He is currently Chair of PRASA and a board member of AACP and Southern Cross Care having recently retired from the PSA National Board. He has also served on the South Australian Domiciliary Medication Management Review Implementation Committee and served on SA diabetes and asthma committees. A Fellow and Life Member of the PSA, he was awarded the Barry Schultz Medal for Excellence in Pharmacy by the Pharmacy Guild of Australia in 2013. Grant was a community pharmacist owner for many years, and he views practice change as an important foundation to integrate new initiatives into a pharmacy model that is sustainable and viable in the future to ensure patients have the best possible health outcomes.

Professor Nigel Stocks
Nigel is Head of the Discipline of General Practice at the University of Adelaide and Director of the only national Primary Care Committee and deputy chair of the Vaccine Preventable Disease Advisory Group for SA. He is an experienced primary health care researcher who has conducted large and small RCT’s in general practice but also with an interest in qualitative and health services research. His main areas of interest include cardiovascular and infectious disease, prevention and quality of life. For several years he was the RACGP SA/NT Faculty Chair, a member and Chair of their national Council and member of their research committee.

Professor Carl Kirkpatrick
Carl is a Professor of Pharmacy Practice at the Monash Institute of Pharmaceutical Sciences, Monash University. He has an international track record in the application of quantitative clinical pharmacology for drug development and optimising older medications, as well as extensive experience in pharmacy education, including the development of guidelines and educational content for healthcare professionals. He is currently the immediate past president of the Australian Society of Clinical and Experimental Pharmacologists and Toxicologists.

Dr Rebekah Hoffman
Dr Hoffman is a specialist GP and a fellow of the Royal Australian College of General Practice. She is currently completing a PhD at the University of Wollongong. Dr Hoffman is a peer representative on the Medical Council and Professional Services Review panels, and also represents local GPs on a number of committees, boards, and faculties, she is currently a Board Director for the RACGP. She is a co-owner at Kirrawee Family Medical Practice and Woolooware Family Medical Practice.

A/Professor Ingrid Hopper
Associate Professor, Health Systems Services & Policy, Victorian Heart Institute. Ingrid Hopper is a consultant physician, trained in clinical pharmacology. She completed her PhD and post-doctoral research fellowship at Monash University School of Public Health and Preventive Medicine. She is a researcher at the Department of Epidemiology and Preventive Medicine at Monash University, and a consultant physician at the Alfred Hospital. Her research covers diverse areas of therapeutics. She is principal investigator on the NHMRC funded STAREE-HEART study investigating whether statins prevent heart failure and atrial fibrillation in healthy elders, an ancillary study of the statins in Reducing Events in the Elderly (STAREE) study which is the largest randomised clinical trial currently recruiting in Australia.